国际医药卫生导报2019，Vol.25Issue(14)：2326-2327,2.DOI:10.3760/cma.j.issn.1007-1245.2019.14.036
阿司匹林联合华法林对冠心病合并心房纤颤患者的安全性和有效性分析
Aspirin combined with warfarin for patients with coronary heart disease complicated with atrial fibrillation
陈硕 1何荣华 1邱俊英 1饶国涛 1王琼涛 1鲁志科 1张进锋 1李鹏飞1
作者信息
摘要
Abstract
Objective To investigate the effect of aspirin combined with warfarin for patients with coronary heart disease and atrial fibrillation.Methods 107 patients with coronary heart disease and atrial fibrillation admitted to our hospital were divided into an observation group (aspirin combined with warfarin group) and a control group (warfarin group).The situation and occurrence of bleeding events were recorded and analyzed.Results The incidence of thromboembolism was lower in the observation group than in the control group [3.85％ (2/52) vs.16.36％ (9/55);P ＜ 0.05].There was no statistical difference in the incidence of bleeding events between the two groups (P ＞ 0.05).Conclusion Aspirin combined with warfarin for patients with coronary heart disease and atrial fibrillation can reduce the risk of thromboembolism,and the risk of bleeding is not superimposed,which ensures the medication safety.关键词
心房纤颤/阿司匹林/华法林Key words
Atrial fibrillation/Aspirin/Warfarin引用本文复制引用
陈硕,何荣华,邱俊英,饶国涛,王琼涛,鲁志科,张进锋,李鹏飞..阿司匹林联合华法林对冠心病合并心房纤颤患者的安全性和有效性分析[J].国际医药卫生导报,2019,25(14):2326-2327,2.
